IglesiasC.G., TorresV.E., OffordK.P.. Epidemiology of adult polycystic kidney disease, Olmsted Country, Minnesota. Am J Kidney Dis1983; 2: 630–9.
3.
BaiwaZ.H., SialK.A., MalikA.B., SteinmanT.I.Pain patterns in patients with polycystic kidney disease. Kidney Int2004; 66: 1561–9.
4.
TorresV.E., WilsonD.M., HatteryR.R., SeguraJ.W.Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis1993; 22: 513–9.
5.
GrampassS.A., ChandhokeP.S., FanJ.. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis2000; 36: 53–7.
6.
LindemanR.D., TobinJ.D., ShockN.W.Association between blood pressure and the rate of decline in renal function with age. Kidney Int1984; 26: 861–8.
7.
KlahrS., BreyerJ., BeckG.. Dietary protein restriction, blood pressure control, and the progression of the polycystic kidney disease modification of diet in renal disease study group. J Am Soc Nephrol1995; 5: 2037–47.
RavineD., GibsonR.N., WalkerR.G.. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet1994; 343: 824–7.
10.
JehangirB., KirmaniO., DarS.Autosomal dominant polycystic kidney disease and nephrolithiasis in a Horseshoe Kidney. A case report. JK-Practioner2006; 13(2): 98–9.
11.
SerioA., FraioliA.Epidemiology of Nephrolitiasis. Nephron1999, 81 (S1): 26–30.
12.
TrinchieriA.Epidemiology of urolithiasis: an update. Clin Cases Mineral Bone Metab2008; 5(2): 101–6.
13.
RomeroV., AkpinarH., AssimosD.G.Kidney stones: a global picture of prevalence, incidence, and Associated risk factors. Reviews in Urology2010; 12(2/3): e86–e96.
14.
WorchesterE.M., CoeF.L.Calcium Kidney Stones. N Engl J Med2010; 363: 954–63.
15.
FineJk, PakC.Y.C., PremingerG.M.Effect of medical management and residual fragments on recurrent stone formation following shock-wave lithotripsy. J Urol1995; 153: 27–33.
16.
MarangellaM.I compiti del nefrologo nella nefrolitiasi. Giorn It Nefrol2005; 22(1): 16–27.
17.
MarangellaM., CossedduD., VitaleC., LinariE.Giorn It Nefrol1993; 10S-3: 81–8.
18.
StewartC.Nephrolithiasis. Emerg Med Clin North Am1988; 6: 617–30.
19.
MelianiE., LombardiM., VanniniR.. Impatto delle coliche renali sul DEA di una grande azienda sanitaria: l'esperienza nell'area fiorentina. Giornale di Tecniche Nefrologiche & Dialitiche2005; XVII(4); 16–8.
20.
WignallG.R., CanalesB.K., DenstedtJ.D., MongaM.Minimally invasive approaches to upper urinary tract urolithiasis. Urol Clin North Am2008; 35: 441–54.
21.
ParksJ.H., CoeF.L.Evidence for durable kidney stone prevention over several decades. BJU Int2009; 103(9): 1238–46.
22.
TiseliusH.G.Solution chemistry of supesaturation. In Kidney Stones. Medical and surgical management. Edited by CoeF.L., FavusM.J., PakC.Y.C., ParksJ.H., PremingerG.M.Lipincott-Raven publishers, Philadelphia1996; Chapter 2: 33–64.
23.
HessB., Jan KokD.Nucleation, growth, and aggregation of stone-forming crystals. In Kidney Stones. Medical and surgical management. Edited by CoeF.L., FavusM.J., PakC.Y.C., ParksJ.H., PremingerG.M.Lipincott-Raven publishers, Philadelphia1996; Chapter 1: 3–32.
24.
LombardiM.Comunicazione personale. Rene Policistico e calcolosi urinaria. Road Show ‘Il rene policistico e le sue manifestazioni’. 3° Corso di aggiornamento per MMG e nefrologi e tavola rotonda con i pazienti. 27 novembre 2010 Aula magna presidenza facoltà di medicina e chirurgia, AOC, Firenze.
25.
ParisiR., BagnisC., PetraruloM.. LithoRisk-2 programma semplificato per il calcolo della saturazione urinaria. In La nefrolitiasi nel terzo Millennio: una patologia di pertinenza multidisciplinare. A cura di Lombardi M, Marangella M e SimeoniP.G. Wichtig Ed. Milano2008: 69–72.
TorresV.E., EricksonS.B., SmithL.H.. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis1988; 11: 3–18.
28.
LevineE., GranthamJ.J.Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. Am J Roentgenol1992; 159: 77–81.
29.
GambaroG., FabrisA., PuliattaD., Lupo A Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res2006; 34: 102–7.
30.
CoeF.L.Calcium kidney stones. N Engl J Med2010; 363: 954–63.
31.
CoeF.L., ParksJ.H.Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med1980; 93: 60–1.
32.
GrampsasS.A., ChandhokeP.S., FanJ.. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis2000; 36: 53–7.
33.
KaehnyW.D., TangelD.J., JohnsonA.M.. Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates. Am J Med1990; 89: 49–52.
TascaA.Metabolic syndrome and bariatric surgery in stone disease etiology. Current Opinion in Urology2011; 21: 129–33.
36.
MinettiL., ColussiG., SurianM.Nefrolitiasi da acido urico. In: Nefrolitiasi. Fisiopatologia e clinica.Acta medica Ed. & Cong. Roma1985; capV: 86.
37.
NishiuraJ.L., NevesRFCA, EloiS.M.R.. Evaluation of Nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol2009; 4: 838–44.
38.
GabowP.A.Autosomal dominant polycystic kidney disease - more than a renal disease. Am J Kidney Dis1990; 16: 403–13.
39.
De MauriA.Rischio radiologico nei pazienti in dialisi. G Ital Nefrol2011; 28(3); 252.
40.
CassA.S.Renal function after extracorporeal shock wave lithotripsy to a solitary kdneyJ Endourol1994; 8: 15–9.
41.
ChandhokeP.S., AlbalaD.M., ClaymanR.V.Long-term comparison of renal function in patients with solitary kidneys and/or moderate renal insufficiency undergoing ESWL or percutaneous nephrolithotomy. J Urol1991; 145: 323A.
42.
CupistiA.Update on nephrolithiasis. J Nephrol2011; 24(Suppl 18); S25–9.
43.
CroppiE., CupistiA., LombardiM.., per il Gruppo Multidisciplinare per la Calcolosi Renale. Percorso diagnostico-trapeutico per il paziente con calcolosi urinaria, G Ital Nefrol2010; 27: 282–9.
44.
RendinaD., MossettiG., De FilippoG.. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant2009; 24: 900–6.
45.
DomingoF., SerraA.Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant2011; 26: 864–8.
46.
BorghiL., SchianchiT., MeschiT.. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med2002; 346: 77–84.
47.
NouvenneA., MeschiT., PratiB.. Effects of a low-salt diet on idiopatic hypercalciuria in calcium oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr2010; 91: 565–70.